semaglutide nz Pharmac (Te Pātaka Whaioranga) in New Zealand is currently seeking #clinical #advice on whether to fund weight loss #medications like (marketed as Wegovy for weight loss or Ozempic for type 2diabetes) Novo Nordisk's Wegovy® (Semaglutide) Set

The gallbladder overlap that complicates the picture The reason pancreatitis and the gallbladder keep getting mentioned together is that they share plumbing and share a risk factor: rapid weight loss

DOI: 10.1016/j.lfs.2019.117139

During this time, adults taking it in clinical trials lost an average of about 10% their starting body weight

Bottom line: Its important for anyone interested in switching diabetes medications to consult their healthcare provider about the risks versus benefits

A patient with type 2 diabetes, hypertension, and obesity who qualifies for a GLP-1 under multiple indications should usually take the Part D diabetes coverage over the Bridge